Olon Group is a global leader in the development and production of Active Pharmaceutical Ingredients (APIs) for CDMO Partners and Generics. We provide an integrated package of chemical synthesis and biological processing services which clients rely on to manage their drug manufacturing projects, in strict compliant with regulations. It provides an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on a global network of 11 manufacturing site and 7 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies. Thanks to 2.300 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. In Olon, expertise and competence are combined with great flexibility at different levels, namely in the field of microbial fermentation processes - always considering human safety and environmental security. Our concrete commitment is to build new sustainability, involving the company in all operations and business aspects. A new sustainability integrates respect for the environment, with that for the people who work for us, through training and inclusiveness. Finally, a new sustainability that positively influences all those with our Company works: suppliers, public and private bodies, and customers. And, of course, we do not forget all those who use the products we have contributed to develop and produce, as we are aware of the value we are generating in their life. To validate all our achievements concerning sustainability, in 2022 we were acknowledged with the Bronze Medal of the EcoVadis rating.